<DOC>
	<DOCNO>NCT02029105</DOCNO>
	<brief_summary>In study , investigator analyze efficiency hyaluronan , osteopontin , C-ERC/mesothelin , N-ERC/mesothelin syndecan-1 serum level , individually combination , distinguish malignant pleural mesothelioma patient patient metastatic malignant pleural disease , benign pleural disease , benign asbestos pleurisy .</brief_summary>
	<brief_title>Serum Biomarkers Diagnosis Mesothelioma</brief_title>
	<detailed_description>In year 2002 , database pleural disease construct prospectively fill department . The finding , outcome feature characteristics follow-up case pleural disease record database . The patient data , include epidemiological characteristic , smoke status , history disease co-morbid condition , previous asbestos exposure , medication additional physical radiological examination finding , include compute tomography scan , serum pleural fluid laboratory investigational data indication invasive procedure , record database mention . The method employ diagnosis patient ; complication ; characteristic stag disease , treatment , course treatment ; result also record database . From date first database establishment , `` tissue , blood , serum , fluid specimen bank '' construct ; tissue , blood , serum pleural fluid sample patient , take begin diagnosis process , store bank -80Â°C . The blood , serum , pleural fluid sample patient store diagnosis process , conduct , pleural tissue sample take invasive procedure also stock .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Patients definite pleural disease Age 18 yearold , less 85 yearold . Willingness participate study . Patients undiagnosed pleural disease . Age less 18 yearold 85 yearold .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Mesothelioma ,</keyword>
	<keyword>Pleural disease ,</keyword>
	<keyword>Mesothelin ,</keyword>
	<keyword>Osteopontin ,</keyword>
	<keyword>Hyaluronan ,</keyword>
	<keyword>Syndecan-1</keyword>
</DOC>